CN104368031A - 一种医用抗菌敷料及其制备方法 - Google Patents
一种医用抗菌敷料及其制备方法 Download PDFInfo
- Publication number
- CN104368031A CN104368031A CN201410624372.1A CN201410624372A CN104368031A CN 104368031 A CN104368031 A CN 104368031A CN 201410624372 A CN201410624372 A CN 201410624372A CN 104368031 A CN104368031 A CN 104368031A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- medical antibacterial
- antibacterial dressing
- artemisia sieversiana
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 85
- 235000004040 Artemisia sieversiana Nutrition 0.000 claims abstract description 49
- 241001201008 Artemisia sieversiana Species 0.000 claims abstract description 49
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 36
- 229920001661 Chitosan Polymers 0.000 claims abstract description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- 239000008367 deionised water Substances 0.000 claims abstract description 24
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 24
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 22
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 22
- 102000008186 Collagen Human genes 0.000 claims abstract description 17
- 108010035532 Collagen Proteins 0.000 claims abstract description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 16
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910021538 borax Inorganic materials 0.000 claims abstract description 16
- 239000001110 calcium chloride Substances 0.000 claims abstract description 16
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 16
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 16
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 15
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 15
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 15
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 15
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 15
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 15
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 15
- 239000000661 sodium alginate Substances 0.000 claims abstract description 15
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 15
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 15
- 239000000600 sorbitol Substances 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 11
- 235000011148 calcium chloride Nutrition 0.000 claims abstract description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 63
- 241000227129 Aconitum Species 0.000 claims description 45
- 238000000605 extraction Methods 0.000 claims description 14
- 239000012467 final product Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 239000003208 petroleum Substances 0.000 claims description 14
- 239000004328 sodium tetraborate Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 7
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 7
- 230000018044 dehydration Effects 0.000 claims description 7
- 238000006297 dehydration reaction Methods 0.000 claims description 7
- 238000004090 dissolution Methods 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 239000012259 ether extract Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000013557 residual solvent Substances 0.000 claims description 7
- PVGBHEUCHKGFQP-UHFFFAOYSA-N sodium;n-[5-amino-2-(4-aminophenyl)sulfonylphenyl]sulfonylacetamide Chemical compound [Na+].CC(=O)NS(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 PVGBHEUCHKGFQP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- LYCAIKOWRPUZTN-NMQOAUCRSA-N 1,2-dideuteriooxyethane Chemical compound [2H]OCCO[2H] LYCAIKOWRPUZTN-NMQOAUCRSA-N 0.000 claims description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 40
- 206010052428 Wound Diseases 0.000 abstract description 39
- 230000036407 pain Effects 0.000 abstract description 4
- 229920001436 collagen Polymers 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 241001586435 Aconitum tanguticum Species 0.000 abstract 3
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 abstract 2
- 235000019837 monoammonium phosphate Nutrition 0.000 abstract 2
- 239000006012 monoammonium phosphate Substances 0.000 abstract 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 10
- 230000029663 wound healing Effects 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 7
- 230000035876 healing Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010000269 abscess Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000016425 Arthrospira platensis Nutrition 0.000 description 3
- 240000002900 Arthrospira platensis Species 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- 241000270295 Serpentes Species 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 229940082787 spirulina Drugs 0.000 description 3
- 230000008359 toxicosis Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 206010048629 Wound secretion Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000265565 Alangium rotundifolium Species 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410624372.1A CN104368031B (zh) | 2014-11-07 | 2014-11-07 | 一种医用抗菌敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410624372.1A CN104368031B (zh) | 2014-11-07 | 2014-11-07 | 一种医用抗菌敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104368031A true CN104368031A (zh) | 2015-02-25 |
CN104368031B CN104368031B (zh) | 2017-05-10 |
Family
ID=52547387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410624372.1A Expired - Fee Related CN104368031B (zh) | 2014-11-07 | 2014-11-07 | 一种医用抗菌敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104368031B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194724A (zh) * | 2015-09-30 | 2015-12-30 | 苏州蔻美新材料有限公司 | 一种水凝胶敷料的制备方法 |
CN105287360A (zh) * | 2015-11-13 | 2016-02-03 | 邢月军 | 具有消炎抗菌功效的医用凝胶 |
CN105641740A (zh) * | 2016-01-05 | 2016-06-08 | 重庆惠森驰恒医疗器械有限公司 | 全面治疗皮肤创伤的生物营养敷料及其制备方法 |
CN105854064A (zh) * | 2016-03-28 | 2016-08-17 | 苏州蔻美新材料有限公司 | 一种透气止血型藻酸盐敷料及其制备方法 |
CN106075562A (zh) * | 2016-07-29 | 2016-11-09 | 江苏蓝湾生物科技有限公司 | 一种负压伤口治疗用护创液的制备方法 |
CN106075533A (zh) * | 2016-07-01 | 2016-11-09 | 赵艳丽 | 一种抗菌生物敷料及其制备方法 |
CN106139240A (zh) * | 2016-07-29 | 2016-11-23 | 江苏蓝湾生物科技有限公司 | 一种用于治疗皮肤溃疡的护创液的制备方法 |
CN107137759A (zh) * | 2015-12-23 | 2017-09-08 | 许盈 | 一种凝胶创口贴及其制备方法 |
CN107158272A (zh) * | 2017-06-08 | 2017-09-15 | 苏州凌科特新材料有限公司 | 一种抗菌消炎医用凝胶剂及其制备方法 |
CN107670098A (zh) * | 2017-11-28 | 2018-02-09 | 苏州汇涵医用科技发展有限公司 | 一种创面愈合液体敷料及其制备方法 |
CN108014362A (zh) * | 2018-02-07 | 2018-05-11 | 苏州元禾医疗器械有限公司 | 一种祛除疤痕的创伤敷料的制备方法 |
CN108030950A (zh) * | 2018-02-07 | 2018-05-15 | 苏州元禾医疗器械有限公司 | 一种祛除疤痕的创伤敷料 |
CN110496145A (zh) * | 2019-10-09 | 2019-11-26 | 中国科学院新疆理化技术研究所 | 一种大籽蒿有效部位的制备方法及其用途 |
CN111110832A (zh) * | 2018-10-15 | 2020-05-08 | 王茂松 | 一种蜗牛提取液和枸骨提取液治愈创伤及疤痕的制剂及其制备方法 |
CN112169014A (zh) * | 2020-09-27 | 2021-01-05 | 浙江丽能生物医药科技有限公司 | 一种sod超氧化物歧化酶促进皮肤表面伤口快速修复的材料及其制备方法 |
CN112426563A (zh) * | 2020-12-02 | 2021-03-02 | 广州立达尔生物科技股份有限公司 | 一种桃金娘提取物制备的液体敷料及其复配方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2512248A1 (en) * | 2003-01-03 | 2004-07-29 | University Of Tennessee Research Foundation | Use of herbs as a delivery system for bioactive phytochemicals |
CN102895164A (zh) * | 2012-09-25 | 2013-01-30 | 石磊 | 一种凝水面膜及其制备方法 |
CN102920615A (zh) * | 2011-08-08 | 2013-02-13 | 陈明智 | 皮肤外用胶体组合物 |
CN103405353A (zh) * | 2013-07-18 | 2013-11-27 | 石磊 | 一种皮肤外用贴膜及其密集渗透生产技术 |
CN103656730A (zh) * | 2013-12-10 | 2014-03-26 | 徐花 | 一种医用壳聚糖敷料 |
CN103800940A (zh) * | 2012-11-14 | 2014-05-21 | 天津禹王生物医药科技有限公司 | 一种止血敷料及制备方法 |
-
2014
- 2014-11-07 CN CN201410624372.1A patent/CN104368031B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2512248A1 (en) * | 2003-01-03 | 2004-07-29 | University Of Tennessee Research Foundation | Use of herbs as a delivery system for bioactive phytochemicals |
CN102920615A (zh) * | 2011-08-08 | 2013-02-13 | 陈明智 | 皮肤外用胶体组合物 |
CN102895164A (zh) * | 2012-09-25 | 2013-01-30 | 石磊 | 一种凝水面膜及其制备方法 |
CN103800940A (zh) * | 2012-11-14 | 2014-05-21 | 天津禹王生物医药科技有限公司 | 一种止血敷料及制备方法 |
CN103405353A (zh) * | 2013-07-18 | 2013-11-27 | 石磊 | 一种皮肤外用贴膜及其密集渗透生产技术 |
CN103656730A (zh) * | 2013-12-10 | 2014-03-26 | 徐花 | 一种医用壳聚糖敷料 |
Non-Patent Citations (4)
Title |
---|
冯洪钱: "《民间兽医本草续编》", 31 January 1989 * |
藏药浴的现代研究;黄福开;《中国藏药浴》;中国藏学出版社;20031130;第115页 * |
雪乌;冯洪钱;《民间兽医本草续编》;科学技术文献出版社;19890131;第340-341页 * |
黄福开: "《中国藏药浴》", 30 November 2003 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194724B (zh) * | 2015-09-30 | 2018-03-16 | 苏州蔻美新材料有限公司 | 一种水凝胶敷料的制备方法 |
CN105194724A (zh) * | 2015-09-30 | 2015-12-30 | 苏州蔻美新材料有限公司 | 一种水凝胶敷料的制备方法 |
CN105287360A (zh) * | 2015-11-13 | 2016-02-03 | 邢月军 | 具有消炎抗菌功效的医用凝胶 |
CN107137759A (zh) * | 2015-12-23 | 2017-09-08 | 许盈 | 一种凝胶创口贴及其制备方法 |
CN105641740A (zh) * | 2016-01-05 | 2016-06-08 | 重庆惠森驰恒医疗器械有限公司 | 全面治疗皮肤创伤的生物营养敷料及其制备方法 |
CN105854064A (zh) * | 2016-03-28 | 2016-08-17 | 苏州蔻美新材料有限公司 | 一种透气止血型藻酸盐敷料及其制备方法 |
CN106075533A (zh) * | 2016-07-01 | 2016-11-09 | 赵艳丽 | 一种抗菌生物敷料及其制备方法 |
CN106075562A (zh) * | 2016-07-29 | 2016-11-09 | 江苏蓝湾生物科技有限公司 | 一种负压伤口治疗用护创液的制备方法 |
CN106139240A (zh) * | 2016-07-29 | 2016-11-23 | 江苏蓝湾生物科技有限公司 | 一种用于治疗皮肤溃疡的护创液的制备方法 |
CN107158272A (zh) * | 2017-06-08 | 2017-09-15 | 苏州凌科特新材料有限公司 | 一种抗菌消炎医用凝胶剂及其制备方法 |
CN107670098A (zh) * | 2017-11-28 | 2018-02-09 | 苏州汇涵医用科技发展有限公司 | 一种创面愈合液体敷料及其制备方法 |
CN108014362A (zh) * | 2018-02-07 | 2018-05-11 | 苏州元禾医疗器械有限公司 | 一种祛除疤痕的创伤敷料的制备方法 |
CN108030950A (zh) * | 2018-02-07 | 2018-05-15 | 苏州元禾医疗器械有限公司 | 一种祛除疤痕的创伤敷料 |
CN111110832A (zh) * | 2018-10-15 | 2020-05-08 | 王茂松 | 一种蜗牛提取液和枸骨提取液治愈创伤及疤痕的制剂及其制备方法 |
CN110496145A (zh) * | 2019-10-09 | 2019-11-26 | 中国科学院新疆理化技术研究所 | 一种大籽蒿有效部位的制备方法及其用途 |
CN112169014A (zh) * | 2020-09-27 | 2021-01-05 | 浙江丽能生物医药科技有限公司 | 一种sod超氧化物歧化酶促进皮肤表面伤口快速修复的材料及其制备方法 |
CN112426563A (zh) * | 2020-12-02 | 2021-03-02 | 广州立达尔生物科技股份有限公司 | 一种桃金娘提取物制备的液体敷料及其复配方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104368031B (zh) | 2017-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104368031B (zh) | 一种医用抗菌敷料及其制备方法 | |
CN101879283A (zh) | 一种用于皮肤外伤的新型喷膜制剂及制备方法 | |
CN105535334A (zh) | 一种紫芪生肌膏及制备方法 | |
CN105250696A (zh) | 一种促进皮肤伤口愈合的中药凝胶剂及其制备方法 | |
CN112316017A (zh) | 一种妇科抑菌凝胶及其制备方法 | |
CN105168385A (zh) | 一种抗菌止痒的药物组合物及其制备方法 | |
CN104922248A (zh) | 一种抗菌、消炎中药复方凝胶剂及制备方法 | |
CN103858946B (zh) | 一种用于术前手术室消毒的喷雾剂及制备方法和使用方法 | |
CN105168361A (zh) | 一种治疗烧烫伤的植物油复方擦剂及其制备方法 | |
CN111012945A (zh) | 一种新型防水中药液体创可贴及其制备方法 | |
CN107595819B (zh) | 一种纳米金刚石改性液体创可贴及其制备方法 | |
CN103007034B (zh) | 用于治疗ⅱ度烧伤残余创面的中药组合物及制备方法 | |
CN105194330A (zh) | 一种促进伤口愈合的中药组合物及其制备方法 | |
CN105560620A (zh) | 一种用于外伤处理的中药制剂 | |
CN108403570A (zh) | 对湿疹引起的皮肤瘙痒有改善效果的体用凝露及制备方法 | |
CN108355042A (zh) | 一种消炎止痛药膏及其制备方法 | |
RU2342955C1 (ru) | Способ получения антисептической пленки | |
CN111514119A (zh) | 一种含工业大麻根提取物的创口贴及其制备方法 | |
CN105536028A (zh) | 促进皮肤创面修复的敷料及制备方法 | |
CN111544523A (zh) | 一种治疗皮肤溃烂的中药组合物及其应用 | |
CN104490970A (zh) | 一种治疗体癣的药物组合物及其制备方法 | |
CN115177782B (zh) | 一种高透气、促愈合的液体创可贴及其制备方法 | |
CN113332365B (zh) | 一种复方紫草膏及其制备方法 | |
CN107243029A (zh) | 一种抑菌洗液及其制备方法和应用 | |
CN108853293B (zh) | 治疗痔疮的复配精油及其制备方法和使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Ming Inventor after: Yu Nina Inventor before: Guo Yuqin Inventor before: Li Yongchao Inventor before: Liu Lefeng |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170410 Address after: 276002 Jiefang Road, Lanshan District, Shandong, China, No. 48, No. Applicant after: Ma Ming Address before: Wuzhong District town Suzhou city Jiangsu province 215128 gold Jinchang Road No. 360 Applicant before: Suzhou Vivotide Biotechnologies Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170510 Termination date: 20171107 |